RecruitingPhase 3

Benefits of ADHD Treatment in Detained People

Switzerland150 participantsStarted 2024-01-01

Plain-language summary

Attention deficit hyperactivity disorder (ADHD) is characterized by difficulties paying attention, poor impulse control, and hyperactive behaviors. It is associated with several health and social detrimental outcomes and leads to increased risks of criminality and recidivism. However, to date, ADHD treatment has been neglected in prison. This project will test the efficacy of ADHD treatment using a randomized controlled trial.

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * age between 18 and 65 * good command of French * stay in prison approx. 4 months at eligibility visit * endorsing clinical diagnostic criteria for DSM-5 ADHD * providing written informed consent Exclusion Criteria: * presence of an acute uncontrolled comorbid psychiatric disorder * medical contraindication to stimulant prescription * potential adverse interaction with another medication * already receive ADHD treatment

What they're measuring

Severity of ADHD core symptoms

Timeframe: 3 months

Trial details

NCT IDNCT05842330

SponsorStéphanie Baggio

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-10-30

View on ClinicalTrials.gov More ADHD trials